Information between 10th July 2025 - 18th October 2025
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
14 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted No - in line with the party majority and in line with the House One of 38 Liberal Democrat No votes vs 1 Liberal Democrat Aye votes Tally: Ayes - 161 Noes - 191 |
|
14 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and in line with the House One of 45 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 232 Noes - 137 |
|
14 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and against the House One of 51 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 65 Noes - 170 |
|
14 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and in line with the House One of 54 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 267 Noes - 153 |
|
14 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and in line with the House One of 54 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 264 Noes - 158 |
|
16 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and in line with the House One of 40 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 248 Noes - 150 |
|
16 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and in line with the House One of 54 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 304 Noes - 160 |
|
16 Jul 2025 - Employment Rights Bill - View Vote Context Baroness Northover voted Aye - in line with the party majority and against the House One of 43 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 100 Noes - 136 |
|
22 Jul 2025 - Enterprise Act 2002 (Mergers Involving Newspaper Enterprises and Foreign Powers) Regulations 2025 - View Vote Context Baroness Northover voted Aye - in line with the party majority and against the House One of 64 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 155 Noes - 267 |
|
13 Oct 2025 - Bus Services (No. 2) Bill [HL] - View Vote Context Baroness Northover voted Aye - in line with the party majority and against the House One of 50 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 57 Noes - 134 |
|
13 Oct 2025 - Bus Services (No. 2) Bill [HL] - View Vote Context Baroness Northover voted No - in line with the party majority and in line with the House One of 50 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 147 Noes - 189 |
|
14 Oct 2025 - Business of the House - View Vote Context Baroness Northover voted No - in line with the party majority and in line with the House One of 52 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 211 Noes - 261 |
|
15 Oct 2025 - Public Authorities (Fraud, Error and Recovery) Bill - View Vote Context Baroness Northover voted No - in line with the party majority and against the House One of 44 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 200 Noes - 194 |
| Speeches |
|---|
|
Baroness Northover speeches from: Gaza City
Baroness Northover contributed 1 speech (94 words) Monday 8th September 2025 - Lords Chamber |
|
Baroness Northover speeches from: Labour Market
Baroness Northover contributed 1 speech (66 words) Monday 8th September 2025 - Lords Chamber Department for Work and Pensions |
|
Baroness Northover speeches from: Official Development Assistance
Baroness Northover contributed 1 speech (72 words) Monday 21st July 2025 - Lords Chamber |
| Written Answers |
|---|
|
Minerals
Asked by: Baroness Northover (Liberal Democrat - Life peer) Thursday 2nd October 2025 Question to the Department for Business and Trade: To ask His Majesty's Government, further to the Written Answer from Baroness Jones of Whitchurch on 7 May (HL6732), when they plan to issue an updated Critical Minerals Strategy. Answered by Lord Leong - Lord in Waiting (HM Household) (Whip) Thanks to the extensive engagement and insights from our industry and expert stakeholders as well as cross-government collaboration, we have developed a powerful new vision and plan for securing critical minerals in the UK. Following the outcome of the multi-year Spending Review and the publication of the Industrial Strategy, the Critical Minerals Strategy will be published later this year. |
|
Drugs: Innovation
Asked by: Baroness Northover (Liberal Democrat - Life peer) Thursday 2nd October 2025 Question to the Department for Science, Innovation & Technology: To ask His Majesty's Government what plans they have to enable Innovate UK to recognise the reclassification of medicines as innovation in their grant assessments. Answered by Lord Vallance of Balham - Minister of State (Department for Energy Security and Net Zero) Innovate UK recognises the role of innovation in the reclassification, repurposing, and reformulation of medicines. Whilst not all competitions will allow funding for post-market products, Innovate UK has supported projects involving repurposing for new indications, novel delivery models, formulation changes, and wraparound technologies to improve patient access. For example, Innovate UK is currently funding Signacor Therapeutics in Northern Ireland to repurpose an existing chemotherapy drug towards the treatment of heart disease. |
|
Drugs: Standards
Asked by: Baroness Northover (Liberal Democrat - Life peer) Wednesday 8th October 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what steps they are taking to support the reclassification of medicines with long histories of safe prescribing to be sold over the counter. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring that medicines meet appropriate standards of safety, quality, and efficacy. A Reclassification Alliance was established between industry, the MHRA, and the Department to explore opportunities for improving the reclassification of medicines in the UK. The MHRA has developed an updated reclassification procedure and in April 2024 published updated reclassification guidance. In November 2024, the MHRA also held a reclassification webinar for industry, which focused on the updated procedure and reclassification guidance. In addition, earlier this year, the Government published a list of conditions and categories identified for potential reclassification. The Government is committed to ensuring that medicines are available to patients in the most convenient and accessible manner, provided that it is safe to do so. The reclassification of medicines from prescription-only to over-the-counter status is a vital part of this commitment. The reclassification agenda aligns with broader Government initiatives, including the NHS 10-Year Health Plan and the Health Sector Strategy, which aim to improve patient access and reduce pressure on general practice through enhanced pharmacy services.
The MHRA welcomes discussions with industry as to how we can assess more applications, especially of novel types, which will aid patient choice in the UK.
|
| Select Committee Documents |
|---|
|
Wednesday 17th September 2025
Agendas and papers - Special Inquiry Committee proposals 2026 Liaison Committee (Lords) Found: evidence, including: • Baroness Scotland KC • Baroness Ashton of Upholland, • Baroness Amos, • Baroness Northover |
|
Tuesday 9th September 2025
Oral Evidence - Royal Society Science and Technology Committee Found: Berkeley; Lord Borwick; Lord Drayson; Lord Lucas; Baroness Neuberger; Baroness Neville-Jones; Baroness Northover |
|
Tuesday 15th July 2025
Oral Evidence - Department for Science, Innovation and Technology Financing and Scaling UK Science and Technology: Innovation, Investment, Industry - Science and Technology Committee Found: Chair); Lord Berkeley; Lord Drayson; Lord Lucas; Baroness Neuberger; Baroness Neville-Jones; Baroness Northover |
|
Wednesday 9th July 2025
Oral Evidence - MIT School of Management Financing and Scaling UK Science and Technology: Innovation, Investment, Industry - Science and Technology Committee Found: Lord Mair (The Chair); Lord Borwick; Lord Lucas; Baroness Neuberger; Baroness Neville-Jones; Baroness Northover |
|
Wednesday 9th July 2025
Oral Evidence - London Stock Exchange Group Financing and Scaling UK Science and Technology: Innovation, Investment, Industry - Science and Technology Committee Found: Lord Mair (The Chair); Lord Borwick; Lord Lucas; Baroness Neuberger; Baroness Neville-Jones; Baroness Northover |
|
Tuesday 8th July 2025
Oral Evidence - National Wealth Fund Financing and Scaling UK Science and Technology: Innovation, Investment, Industry - Science and Technology Committee Found: Chair); Lord Berkeley; Lord Borwick; Lord Lucas; Baroness Neuberger; Baroness Neville-Jones; Baroness Northover |
|
Tuesday 8th July 2025
Oral Evidence - Engineering and Physical Sciences Research Council – UKRI, and Innovate UK – UKRI Financing and Scaling UK Science and Technology: Innovation, Investment, Industry - Science and Technology Committee Found: Chair); Lord Berkeley; Lord Borwick; Lord Lucas; Baroness Neuberger; Baroness Neville-Jones; Baroness Northover |
| Bill Documents |
|---|
|
Jul. 17 2025
HL Bill 89 Running list of amendments – 17 July 2025 Tobacco and Vapes Bill 2024-26 Amendment Paper Found: Welsh Ministers consider it appropriate to consult.” 9 Tobacco and Vapes Bill After Clause 15 BARONESS NORTHOVER |